HotSheets 2011
- Us TOO Board Welcomes New Member
- FDA Approves Xgeva® (denosumab) to Help Prevent Cancer-Related Bone Injury
- US Panel Backs Provenge® for Medicare
- FDA Panel Rejects Prostate Drugs (Avodart® & Proscar®) for Prostate Cancer Prevention
- Could a Prostate Cancer Treatment Raise Colon Cancer Risk?
- Clinical Staging for Prostate Cancer Can’t Predict Likelihood for Recurrence
- Long-Term Effect of Early Postoperative Pelvic Floor Biofeedback on Continence post-RP
- Ask Doctor Snuffy Myers
- Doc Moyad’s “No Bogus Science” Column – “Can dogs really smell prostate cancer in urine?”
- Doctor Chodak’s Bottom Line
- Prostate Biopsies Are Not Associated with Increased Mortality
- DHT May Not Affect Prostate Size But May Reduce Bone Mineral Density
- Read more..
- Special Burning Issues Supplement: A Systems Pathology Approach to Post-Surgical Patients with Anxiety
- Dutasteride Enhances the Predictive Usefulness of PSA As a Screening Test
- Is Prostate Cancer in Older Men More Deadly?
- Us TOO Names New Board Officers, Another Member for 2011
- Popular Online Prostate Cancer Tool Questioned
- Cancer Blood Test Closer to Market
- Older Men Get Less Effective Cancer Care
- Decision Making in Localized Prostate Cancer: Lessons Learned from an Online Support Group
- Ask Doctor Snuffy Myers
- Doc Moyad’s “No Bogus Science” Column – Creatine Supplements
- ADT May Be Tied to Cataracts
- Doctor Chodak’s Bottom Line
- Read more..
- Us TOO 2009 Annual Report Now Available
- Focusing on the Stress of Prostate Cancer
- Gene Test May Spot Lethal Prostate Tumors
- First 5-Year Outcomes Published on CyberKnife Radiosurgery for Prostate Cancer
- Improving Active Surveillance Outcome Using Stringent Enrollment Criteria
- Surgery vs. Radiation for High-Risk Disease
- Multidisciplinary vs. 1-on-1 Medical Care
- Prostate Cancer Support Groups, Health Literacy & Consumerism
- PSA & Confirmatory Biopsy in Surveillance
- Cancer Death Rates in African Americans Still High
- Timely Intervention with Zoledronic Acid Beneficial
- Ask Doctor Snuffy Myers
- Doc Moyad’s “No Bogus Science” Column – “IOM Barely Changes Vitamin D Recommendations”
- Doctor Chodak’s Bottom Line
- Read more..
- Study Knocks Diagnostic Value of PSA Velocity
- Imaging Misses Mark in Prostate Cancer
- Large Study Shows Little Need for PSA Testing Beyond 10 Years Post-Surgery
- PSA Testing Declines a Bit
- Genetic Map of Prostate Cancer Cracked
- Disease-Free Survival Following Salvage Cryotherapy for Biopsy-Proven Radiotherapy-Recurrent Prostate Cancer
- Study Suggests Lower PSA Cutoff for Biopsy
- Ask Doctor Snuffy Myers
- Doc Moyad’s “No Bogus Science” Column – “Resistance Exercises vs. Calcium + Vitamin D”
- Doctor Chodak’s Bottom Line
- Drug (Abiraterone) Works in Most Prostate Cancer Subgroups
- Read more..
- 20% Rise in Number of Cancer Survivors
- PSA Screening Is Higher in Men in Their 70s
- Short Course of ADT Works Well with RT
- Statins + RT More Effective in Prostate Cancer
- New Cancer Drug Heads to Clinical Trials
- Phase I/II Study of TRC105 in Refractory CRPC
- Digoxin Possible Treatment for Prostate Cancer?
- NCCN Continues to Modify Guidelines
- Ask Doctor Snuffy Myers
- Doc Moyad’s “No Bogus Science” Column – “An aspirin a day may reduce the risk of cancer”
- Doctor Chodak’s Bottom Line
- How Prostate Cancer May Spread to Bone
- Read more..
- FDA Approves Abiraterone
- Early Surgery or Watchful Waiting?
- Biopsy May Progress without PSA Changes
- Study Supports Watchful Waiting for Low-Risk Prostate Cancer
- Another Endothelin Blocker Fails
- Upgrade in Gleason Score Between Biopsies & Pathology Following Radical Prostatectomy
- Overtreatment of Men with Low-Risk Prostate Cancer and Significant Comorbidity
- Phase III Trial of Ipilimumab (NCT01057810)
- Supplements Don’t Prevent Prostate Cancer
- Ask Doctor Snuffy Myers
- Doc Moyad’s “No Bogus Science” Column – “Is Omega-3 in fish oil really bad for you?”
- Doctor Chodak’s Bottom Line
- Read more..
- Alpharadin (222Radium Chloride) Improves Overall Survival in Men with Metastatic CRPC
- Early PSA Testing & Risk of Long-Term Death
- Surgery Works in Locally-Advanced Disease
- AS Update from the John Hopkins Experience
- Effect of Surgery Delay in Men Undergoing AS
- NADiA ProsVue – A New Prognostic Prostate Cancer Test (for Post-RP Patients)
- Exelixis Drug Shown to Control Solid Tumors
- Fusion of MRI and Prostate Ultrasound
- Intermittent Vs. Continuous ADT
- Circulating Tumor Cells Predict Drug Response
- Ask Doctor Snuffy Myers
- Doctor Chodak’s Bottom Line
- Doc Moyad’s “No Bogus Science” Column – “___ Dietary Supplement Fights/Kills Prostate Cancer? Should Doc Moyad Support It?”
- Read more..
- Medicare Will Pay for Prostate Cancer Drug
- Long-Term Efficacy of the Phase 1-2 Study of MDV3100 in Advanced Prostate Cancer Patients Before and after Docetaxel Therapy
- New Resource Kit from Us TOO for Men with Advanced Prostate Cancer
- Potential Combinability of Custirsen with MDV3100 and Hsp90 Inhibitors to Enhance Anti-Tumor Activity Against Prostate Cancer
- Kyphon® Balloon Kyphoplasty for Treating Spinal Fractures in Prostate Cancer Patients
- Prostate Cancer in Men Less than 50 Years Old: A Comparison of Race and Outcomes
- Ask Doctor Snuffy Myers
- Doc Moyad’s “No Bogus Science” Column – “You want another reason to lose weight? How about free vitamin D?!”
- Doctor Chodak’s Bottom Line
- Hydrodissection in Nerve-Sparing Radical Prostatectomy Improves Postoperative Potency
- Read more..
- Urine Test May Help Detect / Stratify Prostate Cancer
- For Some Prostate Cancer Patients, Combo Treatment Improved Survival
- Us TOO Names New Board Members for 2011
- Robot Technology May Drive Up Prostate Surgeries
- Letter to the Editors
- New Patient Information Guide for CyberKnife
- Age Adjustment in Active Surveillance
- ADT & 11C-Choline Uptake in PET/CT Scans
- Bone Flare with Abiraterone Treatment
- Ask Doctor Snuffy Myers
- Doc Moyad’s “No Bogus Science” Column – “Some vegetables may reduce the risk of prostate cancer recurring after treatment”
- Doctor Chodak’s Bottom Line
- Read more..
- ADT Does Not Increase Cardiovascular Risk
- Five Genes Liked to Aggressive Prostate Cancer
- VA Adds to List of Agent Orange-Exposed Ships
- Two Clusterin Studies Released
- Good Long-Term QOL after Brachytherapy
- Dendreon & a Diagnostic for Provenge?
- New Online Tool & Tips on Bone Health
- New Provenge Plant Opens in California
- Valvoline Supports Prostate Cancer Awareness
- Elastography Beats Ultrasound for Detection
- Ask Doctor Snuffy Myers
- Doc Moyad’s “No Bogus Science” Column – “Sage supplement may reduce hot flashes”
- ERG Unrelated to PSA Recurrence w/o ADT
- Doctor Chodak’s Bottom Line
- Read more..
- USPSTF Says PSA Test Does Not Save Lives
- FDA Approves Prolia for Treating Bone Loss in Men and Women on Hormone Ablation
- Erections after Prostate Treatment Predicted by Models
- Us TOO Seeks Board Member Applications
- Ask Doctor Snuffy Myers
- Call to Action – Comment on USPSTF’s Draft Recommendation Statement Against PSA-Based Screening for Prostate Cancer
- SEA Blue Prostate Walk Shines Despite Rain
- 2011 Us TOO University Opens Diaglogue With Support Group Leaders
- Doc Moyad’s “No Bogus Science” Column – 1) Vitamin E and Prostate Cancer Death; 2) What the USPSTF Should Have Stated
- Doctor Chodak’s Bottom Line
- Read more..
- Share Hope and Donate to Us TOO
- MDV3100 Trial Stopped as Survival Improved
- Top Doctors Support PSA Screening in Men
- Brachytherapy & Risk of a Second Cancer
- Antibiotic Change Before Prostate Biopsy
- Men with a Family History of Prostate Cancer Do Not Need More Aggressive Treatment
- ADT Duration & Risk of Prostate Cancer Death
- New NCI Trial for Taxotere-Resistance Cancer
- Quanterix PSA Test to Predict PSA Recurrence
- Ask Doctor Snuffy Myers
- [11C]choline PET-CT for Detecting Pelvic Nodes
- Doc Moyad’s “No Bogus Science” Column – “Metformin and Lifestyle Changes”
- Doctor Chodak’s Bottom Line
- RT + ADT Extends Life in Advanced Cancer
- Read more..